Ovarian cancer is the fourth most common cancer in women and the second most common gynaecological cancer (Harries and Gore, 2002a, 2002b). Although the 5-year survival rate for women with low-risk ...

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, ...

Patients with cancer are frequently anaemic, with contributing factors including chemotherapy and the anaemia of chronic disease, with endogenous erythropoietin deficiency, relative erythropoietin ...

Value of caregiver ratings in evaluating the quality of life of patients with cancer. More than 500 community-based oncologists enrolled 2,342 patients with malignancies undergoing cytotoxic ...

Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, retrospective review of the hospitalwide use of ...

针对红细胞生成刺激剂（ESAs）治疗低危骨髓增生异常综合征（LR-MDS）输血依赖（TD）贫血疗效有限的问题，研究人员开展 COMMANDS 试验，对比 Luspatercept 与阿法依泊汀。结果显示 Luspatercept 显著提升≥1 年及≥1.5 年输血独立性（TI）率，支持其作为优选治疗。

To our knowledge, our findings are the first data reporting on epoetin versus darbepoetin use for CIA and support recently concluded lawsuits involving allegations of illegal marketing practices of ...

The Hematology and Oncology Clinics of three US medical centres - Dartmouth-Hitchcock Medical Center (Lebanon, NH), Pacific Shores Medical Group (Long Beach, CA) and South Carolina Oncology Associates ...

Roxadustat met both primary efficacy endpoints of mean hemoglobin (Hb) change from baseline and proportion of patients achieving Hb response in HIMALAYAS WASHINGTON, Nov. 07, 2019 (GLOBE NEWSWIRE) -- ...

This week, the FDA released MedWatch alerts regarding the safety of three oncologic therapeutic agents. Chromic Phosphate P 32, erlotinib and epoetin alfa were associated with adverse events, an ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Epoetin Alfa refers to erythropoietin (EPO). EPO in the human body is a hormone-like substance secreted by the ...

Epoetin alfa administered to patients with STEMI within 4 hours of successful percutaneous coronary intervention was shown to increase the rate of adverse CV events while having no benefit on infarct ...